CORRECTION: HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals (1-for-10 Reverse Stock Split) - Headline Earlier Published on 9th Aug
CORRECTION: HC Wainwright & Co. Maintains Buy on Rigel Pharmaceuticals (1-for-10 Reverse Stock Split) - Headline Earlier Published on 9th Aug
更正:HC Wainwright&Co.继续为Rigel Pharmaceuticals(1比10反向股票拆分)保持买入——标题于8月9日早前发布
HC Wainwright & Co. analyst Joseph Pantginis maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy with 1-for-10 Reverse Stock Split.
HC Wainwright & Co.分析师Joseph Pantginis维持Rigel Pharmaceuticals(纳斯达克:rigel pharmaceuticals)的买入评级,同时进行1比10的股票拆分。